The center will focus on digital and robotic surgery, showcasing Smith + Nephew Real Intelligence ecology products and providing training in orthopedics, sports medicine, ear, nose and throat and advanced wound management across all product portfolios.
Healthcare professionals will benefit from digital training technology, including interactive LED displays, augmented and virtual reality, and digital operating units on hand. The specially designed digital app integrates all aspects of the learning journey, including allowing participants to design their own agendas, sign up for upcoming events, touch-free enrollment, hold virtual or added reality sessions, and acquire training modules on Smith + nephew learning management. System, education unlimited.
Smith + Brother APAC President, Mira Essex “We are very pleased to have established a world-class training center in the region that will provide our healthcare professionals from top to bottom all over the world. Asia-Pacific Region. In line with our company’s mission and strategic business objectives, this next-generation center will be critical to providing engaging, engaging and interactive training as well as advancing our businesses.
Supporting the unlimited purpose of life of Smith + Nephi, the Medical Education Center, along with its application and unrestricted learning, aims to improve the learning process of healthcare professionals to achieve better patient outcomes. The new institution in Singapore A recent addition to the Smith + nephew global network, which includes owned centers in. Europe And US.
About Smith + nephew
Smith + Nephew is a portfolio of medical technology technology that uses technology to restore the body and self-confidence. We call this purpose ‘Life Unlimited’. Our 18,000 employees deliver this mission every day, innovating and implementing new technologies in product portfolios, including three international orthopedics, advanced wound care and sports therapy and ENT.
Founded in Hall, UKA.D. In 1856 we now operate in more than 100 countries and bring in annual sales $ 4.6 billion A.D. In 2020. Smith + Nephew is part of the FTSE100 (LSE: SN, NYSE: SNN). The words ‘group’ and ‘smith + nephew’ are used to refer to Smith and Nephew plc and the consolidated branch office, unless the context is opposite.
This document may contain forward-looking statements that may or may not be accurate. For example, the expected revenue growth and marketing margins, market trends and statements about our pipeline are expected in the future. Sayings such as “purpose”, “plan”, “thought”, “prediction”, “well-laid”, “believe”, “guess”, “wait”, “target”, “contemplate” and so on are generally considered. To identify future statements. Predictable statements may make you aware of known and unknown concerns, uncertainties, and other important factors that are different from the objectives described or described in the statements. For Smith + Nephew, these include catch-up risks related to CVD-19, such as the depth and longevity of the impact, government action and other restrictive measures taken, material delay and cancellation of election procedures, reduced capacity in medical institutions, sales representatives for medical institutions. Accessibility, or our ability to implement business continuity plans due to Covid-19. Economic and financial conditions in the markets we serve, particularly affecting healthcare providers, payers and customers (unlimited, due to Covid-19). Price levels for established and innovative medical equipment; Advances in medical technology; Regulatory approvals, compensation decisions or other government actions; Problems or related regulations with product defects or notes or other quality management systems; Litigation related to patents or other claims; Law enforcement concerns and related investigative, remedial, or enforcement actions; Disruption by supply chain or operations or by our suppliers (including unrestricted copycat-19); Competition for qualified staff; Success in strategic actions, including acquisitions and incentives; Disruption caused by transactions or other changes in our business plan or organization to adapt to market growth; And many other issues that affect us or our markets, including political, economic, commercial, competitive, or reputable. Please refer to the documents provided by Smith + Nephew to the US Securities and Exchange Commission in accordance with the 1934 US Securities Exchange Act. These reasons. Any future view statement is based on information available to Smith + Nephi from the date of the statement. All textual or verbal forward statements made by Smith + Nephi are worthy of this caution. Smith + Nephew is under no obligation to update or revise any future statement to reflect changes in circumstances or Smith + Nephi.
™ Smith + nephew trademark. Some marks registered with the US Patent and Trademark Office.
Source Smith & Nephew plc
For more information, see David Snyder, Smith + Nephew, +1 978-749-1440, http://www.smith-nephew.com